<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11384532</article-id><article-id pub-id-type="pmc">2631808</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Poirel</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Rotimi</surname><given-names>V. O.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mokaddas</surname><given-names>E. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Karim</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nordmann</surname><given-names>P.</given-names></name></contrib></contrib-group><aff>Facult&#x000e9; de M&#x000e9;decine Paris-Sud, Le Kremlin-Bic&#x000ea;tre, France.</aff><pub-date pub-type="ppub"><season>May-Jun</season><year>2001</year></pub-date><volume>7</volume><issue>3</issue><fpage>468</fpage><lpage>470</lpage><abstract><p>Two clinical Pseudomonas aeruginosa isolates from patients in intensive care units in Kuwait were resistant to expanded-spectrum cephalosporins and showed a synergistic effect between ceftazidime and clavulanic acid. This is the first report of extended-spectrum enzymes from nosocomial isolates from the Middle East.</p></abstract></article-meta></front></article>